Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antidepressive Agents”

105 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 105 results

Testing effectiveness (Phase 2)Study completedNCT00358631
What this trial is testing

An Eight-Week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Major Depressive Disorder

Who this might be right for
Depressive Disorder
Sanofi 319
Large-scale testing (Phase 3)Study completedNCT00250601
What this trial is testing

An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression

Who this might be right for
Depressive Disorder
Sanofi 460
Not applicableActive Not RecruitingNCT05331599
What this trial is testing

Recurrence Markers, Cognitive Burden and Neurobiological Homeostasis in Late-Life Depression

Who this might be right for
Depression in Old AgeRecurrenceCognitive Dysfunction
University of Illinois at Chicago 210
Large-scale testing (Phase 3)Study completedNCT00096798
What this trial is testing

Ethyl Eicosapentanoic Acid (Ethyl-EPA) for Treating Major Depression

Who this might be right for
Depressive DisorderDepression
National Center for Complementary and Integrative Health (NCCIH) 80
Post-approval studies (Phase 4)Study completedNCT00433121
What this trial is testing

Discontinuation of Antipsychotics and Antidepressants Among Patients With BPSD

Who this might be right for
Dementia
Sykehuset Innlandet HF 24
Testing effectiveness (Phase 2)Study completedNCT02021669
What this trial is testing

Omega-3 for Depression and Other Cardiac Risk Factors - 2

Who this might be right for
Depression
Washington University School of Medicine 144
Large-scale testing (Phase 3)Study completedNCT00000369
What this trial is testing

Maintenance Therapies in Bipolar Disorders

Who this might be right for
Bipolar Disorder
University of Pittsburgh
Testing effectiveness (Phase 2)Looking for participantsNCT06511908
What this trial is testing

Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression

Who this might be right for
SuicideDepressive Disorder, Treatment-ResistantKetamine+10 more
National Institute of Mental Health (NIMH) 50
Large-scale testing (Phase 3)Study completedNCT00345098
What this trial is testing

SR58611A in the Prevention of Depression Relapse in Patients With Major Depressive Disorder

Who this might be right for
Depressive DisorderMajor Depression
Sanofi 704
Not applicableStudy completedNCT00115362
What this trial is testing

Serotonin Effect in Functional Dyspepsia

Who this might be right for
Dyspepsia
Radboud University Medical Center 300
Post-approval studies (Phase 4)Study completedNCT00243477
What this trial is testing

MOTIV Study- Effect of Antidepressive Treatment by Escitalopram in Patients Undergoing Coronary Artery Bypass Grafting

Who this might be right for
Coronary Artery Disease
Hopital Jean Minjoz 368
Not applicableActive Not RecruitingNCT06907134
What this trial is testing

The Purpose of the Study is to Investigate if a Smartphone App Combined With Internet Based Cognitive Behavioural Therapy (ICBT) Leads to Improved Symtoms in Depressive Adults on Antidepressive Medicine, Compared to a Wait-list Control Condition

Who this might be right for
Depressive Symptoms
Linkoeping University 150
Not applicableUnknownNCT04169230
What this trial is testing

Citalopram and Self Emotional Processing

Who this might be right for
Molecular Mechanisms of Pharmacological ActionDepressionDepressive Disorder+3 more
University of Oxford 44
Post-approval studies (Phase 4)Study completedNCT02590874
What this trial is testing

The Use of Duloxetine for Cognition Improvement in Individuals With Mild Cognitive Impairment

Who this might be right for
Mild Cognitive ImpairmentDepression
University of North Texas Health Science Center 19
Post-approval studies (Phase 4)UnknownNCT00162916
What this trial is testing

Antidepressant Maintenance in Traumatic Brain Injury

Who this might be right for
Depression
Ontario Neurotrauma Foundation 21
Not applicableStudy completedNCT00005013
What this trial is testing

Treatment of Major Depression With St. John's Wort (Hypericum)

Who this might be right for
Major Depression
National Institute of Mental Health (NIMH)
Post-approval studies (Phase 4)Study completedNCT01778907
What this trial is testing

Cytochrome P450-2D6 Screening Among Elderly Using Antidepressants (CYSCE)

Who this might be right for
DepressionDepressive DisorderPoor Metabolizer Due to Cytochrome P450 CYP2D6 Variant+2 more
University of Groningen 202
Post-approval studies (Phase 4)UnknownNCT02625155
What this trial is testing

Standard of Care Versus Urine Testing With Selective PHarmacogenomics for Effective Drug and Dosing REgimens

Who this might be right for
Target Drug-related Adverse Events
InSource Diagnostics 14,000
Large-scale testing (Phase 3)Study completedNCT02659085
What this trial is testing

Ketamine as an Alternative Treatment to ECT in Major Depressive Disorder

Who this might be right for
Depressive Disorder, Major
Pouya Movahed Rad 198
Large-scale testing (Phase 3)Study completedNCT00336713
What this trial is testing

A 24-52-week Study to Evaluate the Long-term Efficacy and Safety of Saredutant in Patients With Depression (MAGENTA)

Who this might be right for
Depressive Disorder
Sanofi 430
Load More Results